FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/08/2024
Voltar para busca
Dado oficial do USPTO
CELAID THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
11/08/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 40, 42, 44
Data de depósito
18/05/2022
Data de registro
12/03/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/03/2024
Última transação
12/03/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
JP
Examinador
CASE, LEIGH
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized word "CELAID" with the letters "CELA" and "D" in black and the letter "I" in pink. The stylized word "THERAPEUTICS" appears below in black. To the left of the wording, the design of two irregular circles appears, with the lower circle in pink and the upper circle in blue. The overlapping area of the circles appears in purple.
Titulares e representantes
Titulares
Celaid Therapeutics Inc.
Representantes
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical reagents for non-medical purposeschemicals for use in the manufacture of pharmaceuticals; reagents for scientific and research use
Classe 5
Pharmaceutical preparations for the prevention and treatment of cancers; pharmaceutical preparations for the prevention and treatment of hematological malignancies; pharmaceutical preparations for the prevention and treatment of non-hematological malignancies; pharmaceutical preparations for the prevention and treatment of genetic disorders; pharmaceutical preparations for use as gene therapy agent; pharmaceutical preparations for use as regenerative medicine agent; cells for medical use; blood products for the prevention and treatment of cancers; blood products for the prevention and treatment of hematological malignancies; blood products for the prevention and treatment of non-hematological malignancies; blood products for the prevention and treatment of genetic disorders; blood products for use as gene therapy agent; blood products for use as regenerative medicine agent; blood for medical purposes; hemotropic agents for stimulation of cell functiongene therapycell therapyfor use as blood substitutes; cellular function activating agents for medical purposes; reagents for medical use; cell preparations for the treatment of diseases and disorders; clinical diagnostic reagents; stem cells for medical purposes
Classe 40
Treatment and processing of human cells for others; treatment and processing of cells for medical use; cryogenic preservation; custom manufacture of pharmaceutical preparations for others; treatment and processing of blood and blood products
Classe 42
Testinginspection or research of pharmaceuticalscosmetics or foodstuffs
Classe 44
Blood testing and analysis; provision of information on blood tests; providing medical information and consultation; blood bank services; rental of blood filtration units; medical services relating to the removaltreatment and processing of human bloodumbilical cord bloodhuman cellsstem cells and bone marrow
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
19/07/2024
FIMP
FINAL DISPOSITION PROCESSED
19/07/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/06/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
13/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/01/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
24/01/2024
GPNX
NOTIFICATION PROCESSED BY IB
26/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/12/2023
PUBO
PUBLISHED FOR OPPOSITION
26/12/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/12/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/12/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/11/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/11/2023
RFNT
REFUSAL PROCESSED BY IB
24/05/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/05/2023
RFRR
REFUSAL PROCESSED BY MPU
01/05/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/03/2023
CNRT
NON-FINAL ACTION WRITTEN
10/03/2023
DOCK
ASSIGNED TO EXAMINER
08/03/2023
MAFR
APPLICATION FILING RECEIPT MAILED
23/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/08/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/08/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELAID THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.